StockData
Bio-Rad Laboratories, Inc. logo

Bio-Rad Laboratories, Inc. (BIO) income statement

BIONYSELaboratory Analytical InstrumentsFiscal year ends December 31Also trades as BIO.B
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 8/3060% above fair value
$370.17+11.98 (+3.34%)

Close on Nov 18, 2026Market cap $10.00BP/E 45.3Yield –

Bio-Rad Laboratories, Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
51.9%
Operating margin
2.1%
Net margin
8.6%
Return on equity, FY2025
10.8%

Financial strength

Current ratio
3.14
Debt to equity
0.11
Debt to assets
7.8%
Cash to current liabilities
53.8%

Valuation

P/E ratio
45.3
Price to sales
3.86
Price to book
1.39
Dividend yield
–

See a number that looks wrong?